Abstract:Ethnopharmacological relevance Uncaria rhynchophylla (Miq.) Miq. ex Havil. (UR), a traditional Chinese medicinal plant, plays an active role in neuroprotection. Clinical medication and modern pharmacological studies have proved the efficacy of UR against Parkinson's disease (PD), with alkaloids being recognized as the main bioactive components. But the therapeutic effect and mechanism U. rhynchophylla alkaloid extract (URA) against PD need further exploration. Aim of study The study aimed to investigate the therapeutic effect and potential mechanism of URA on PD. Materials and methods LC-MS methodology were used to evaluate the chemical constituents of URA. The anti-PD activity of URA in vivo were measured on the mice and rat model of PD. Neuroprotective effect of URA on PC12 cells was measured by MTT assay. Dopamine (DA) and its metabolism were detected by LC-MS for probing the protection ability on dopaminergic neurons. The differentially expressed protein between model group and URA administrated group were analyzed by proteomics, suggesting oxidative phosphorylation as possible pathway of URA. Considering the critical role of mitochondria in oxidative phosphorylation, JC-1 staining, MitoSOX staining assay, transmission electron microscopy (TEM) observation and adenosine triphosphate (ATP) levels detection were used to analyze the effects of URA on mitochondrial morphology and function. Biolayer interferometry (BLI) was used to search for the possible UCHL1-bonding compounds in URA. Results URA significantly mitigated the behavioural defects by improving coordination, shortening the time to climb down the whole pole (T-LA) and increasing the forelimbs' muscle strength of MPTP-induced PD mice and 6-OHDA-induced PD rats. In addition, URA improved tyrosine hydroxylase expression in dopaminergic neurons by IHC staining, and thus increased the neurotransmitter levels of DA and relevant metabolites. Furthermore, URA promoted mitophagy as reflected by a significant decrease in reactive oxygen species (ROS) generation, an increase in ATP levels and clearance of damaged mitochondria. Subsequently, Ubiquitin C-terminal hydrolase 1 (UCHL1), which is associated with the mitochondrial dysfunction in PD, is suggested to be a promising target based on the proteomics result, and proved by the blocked protective effects of URA by UCHL1 inhibitor. Furthermore, hirsuteine (HTE) was identified as a potential active compound of URA binding to UCHL1 by BLI, and the binding strength and site were verified by surface plasmon resonance (SPR) and molecular docking. Conclusion This work demonstrates that URA exerts effective neuroprotective activity against PD via activation of mitophagy with the involvement of UCHL1, and HTE may be a potential active compound of URA.

Interaction of the ubiquitin carboxyl terminal esterase L1 with α2-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation

Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy.

The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility

Membrane-Associated Farnesylated Uch-L1 Promotes Alpha-Synuclein Neurotoxicity and is A Therapeutic Target for Parkinson'S Disease

Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease

Endoplasmic Reticulum Stress Contributes to the Cell Death Induced by UCH-L1 Inhibitor.

Uncaria rhynchophylla alkaloid extract exerts neuroprotective activity against Parkinson's disease via activating mitophagy with the involvement of UCHL1

Ubiquitin Hydrolase Uch-L1 Rescues Β-Amyloid-induced Decreases in Synaptic Function and Contextual Memory

Regulation of Α2a Adrenergic Receptor Trafficking and Signaling by Amyloid Precursor Protein

Functional interaction of ubiquitin ligase RNF167 with UBE2D1 and UBE2N promotes ubiquitination of AMPA receptor

Neurotoxicity of Ubiquitin C-terminal Hydrolase L1 Inhibitor in Dopaminergic Neurons

Functional Relationships between L1CAM, LC3, ATG12, and Aβ

LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson’s Disease Cell Model

Urolithin A-activated autophagy but not mitophagy protects against ischemic neuronal injury by inhibiting ER stress in vitro and in vivo.

Ube2v1 Positively Regulates Protein Aggregation by Modulating Ubiquitin Proteasome System Performance Partially Through K63 Ubiquitination

Signaling mechanism underlying α2A -adrenergic suppression of excitatory synaptic transmission in the medial prefrontal cortex of rats.

Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism

The Intracellular Domain Of L1cam Binds To Casein Kinase 2 Alpha And Is Neuroprotective Via Inhibition Of The Tumor Suppressors Pten And P53

Identification of ellagic acid and urolithins as natural inhibitors of Aβ25-35-induced neurotoxicity and the mechanism predication using network pharmacology analysis and molecular docking

The Protective Effect of UBE2G2 Knockdown Against Atherosclerosis in Apolipoprotein E-Deficient Mice and Its Association with miR-204-5p

Ubiquitin Carboxyl Terminal Hydrolase L1 Negatively Regulates TNFalpha-mediated Vascular Smooth Muscle Cell Proliferation Via Suppressing ERK Activation.